Oxford Biomedica plc
Overview
Oxford Biomedica plc is a leading gene and cell therapy group focusing on the development and commercialization of novel gene-based therapies. With expertise in viral vector bioprocessing, the company partners with pharmaceutical and biotechnology companies to bring experimental treatments to market.
Core services & business areas
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Oxford Biomedica plc in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Oxford Biomedica plc? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.